Target Name: H2BC12L
NCBI ID: G54145
Review Report on H2BC12L Target / Biomarker Content of Review Report on H2BC12L Target / Biomarker
H2BC12L
Other Name(s): histone H2B.s | H2B.S histone 1 | histone protein | H2B histone family, member S (pseudogene) | H2BFS | H2B/s | H2B histone family member S | H2BS1 | H2B clustered histone 12 like

H2BC12L: A Potential Drug Target and Biomarker

Hepatitis B virus (HBV) is a highly infectious and chronic disease that affects millions of people worldwide. The virus causes liver damage and can lead to various health complications, including liver cancer. Currently, there is no cure for HBV, and treatments are often limited to managing symptoms and preventing complications. The search for new treatments and biomarkers for HBV has led to the discovery of H2BC12L, a potential drug target and biomarker.

H2BC12L is a protein that is expressed in the liver and has been shown to be involved in the replication of HBV. It plays a crucial role in the virus's infection and replication, and is considered a potential drug target. The H2BC12L protein has unique folds and is composed of two transmembrane domains and an extracellular loop. It is expressed in the liver and is involved in the viral replication process.

Research has shown that H2BC12L is a key regulator of the hepatitis B virus replication. It plays a vital role in the initiation of viral replication, and is required for the virus to infect new cells. The H2BC12L protein has been shown to interact with several viral and host factors, including the viral envelope protein E1 and the host factor NS1.

H2BC12L has also been shown to be a potential biomarker for HBV infection. The protein is expressed in the liver and is considered to be a reliable indicator of the virus's presence. The H2BC12L protein has been shown to be upregulated in HBV-infected cells, and its levels have been used as a marker for the disease.

The discovery of H2BC12L as a potential drug target has significant implications for the treatment of HBV. The protein is involved in the virus's replication process, and blocking its function could be a promising approach to treating the disease. H2BC12L has been shown to interact with several viral and host factors, including the viral envelope protein E1 and the host factor NS1. This suggests that blocking H2BC12L could be an effective way to treat HBV.

In addition to its potential as a drug target, H2BC12L has also been shown to be a potential biomarker for HBV infection. Its levels have been shown to be upregulated in HBV-infected cells, and its levels have been used as a marker for the disease. This suggests that H2BC12L could be a useful diagnostic tool for HBV infection, and its levels could be used to monitor the effectiveness of different treatments.

In conclusion, H2BC12L is a protein that is expressed in the liver and has been shown to be involved in the replication of HBV. Its unique folds and composition make it a potential drug target, and its involvement in the virus's replication process and its potential as a biomarker make it an attractive target for research. Further studies are needed to fully understand the role of H2BC12L in the HBV replication process and its potential as a drug and biomarker.

Protein Name: H2B Clustered Histone 12 Like

The "H2BC12L Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about H2BC12L comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

H2BC13 | H2BC14 | H2BC15 | H2BC17 | H2BC18 | H2BC20P | H2BC21 | H2BC26 | H2BC27P | H2BC3 | H2BC4 | H2BC5 | H2BC6 | H2BC7 | H2BC8 | H2BC9 | H2BP1 | H2BP2 | H2BP3 | H2BW1 | H2BW2 | H2BW4P | H3-3A | H3-3B | H3-4 | H3-5 | H3-7 | H3C1 | H3C10 | H3C11 | H3C12 | H3C13 | H3C14 | H3C15 | H3C2 | H3C3 | H3C4 | H3C6 | H3C7 | H3C8 | H3P16 | H3P36 | H3P37 | H3P44 | H3P5 | H3P6 | H4C1 | H4C11 | H4C12 | H4C13 | H4C14 | H4C15 | H4C16 | H4C2 | H4C3 | H4C4 | H4C5 | H4C6 | H4C7 | H4C8 | H4C9 | H6PD | HAAO | HABP2 | HABP4 | HACD1 | HACD2 | HACD3 | HACD4 | HACE1 | HACL1 | HADH | HADHA | HADHAP1 | HADHB | HAFML | HAGH | HAGHL | HAGLR | HAGLROS | HAL | HAMP | HAND1 | HAND2 | HAND2-AS1 | HAO1 | HAO2 | HAO2-IT1 | HAP1 | HAPLN1 | HAPLN2 | HAPLN3 | HAPLN4 | HAPSTR1 | HAR1A | HAR1B | HARBI1 | HARS1 | HARS2 | HAS1